Biotissue Holdings, Inc
Clinical trials sponsored by Biotissue Holdings, Inc, explained in plain language.
-
New eye drop shows promise for dry eye relief
Symptom relief CompletedThis study tested a new eye drop called TTAX03 in 74 adults with mild to moderate dry eye disease. The goal was to see if it is safe and if it helps relieve symptoms like dryness and eye surface damage. Participants received a single dose of TTAX03 or a saline (salt water) placeb…
Phase: PHASE2 • Sponsor: BioTissue Holdings, Inc • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC
-
New knee injection shows promise for arthritis sufferers
Symptom relief CompletedThis study tested a single injection of TTAX03 in 90 adults with severe knee osteoarthritis (grades 3-4). The goal was to see if it reduces pain and improves function better than a placebo (saline) injection after 12 weeks. Researchers measured how many people felt at least a 20-…
Phase: PHASE2 • Sponsor: BioTissue Holdings, Inc • Aim: Symptom relief
Last updated May 08, 2026 12:04 UTC